This page shows the latest pricing news and features for those working in and with pharma, biotech and healthcare.
The 12 key goals on Act4Biosimilars.com have been identified by the Steering Committee using the ‘4As’ criteria, which include: ensuring equitable pricing, involving patients in treatment decisions and streamlining biosimilar
As one of the Coalition partners, AstraZeneca’s global vice president of oncology market access and pricing, Beth Hamilton, said: “A critical component of reducing cancer mortality is improving equity in
Provided that local systems allow it, EFPIA firms are now committed to file for pricing and reimbursement in all EU countries as soon as possible – no later than two years from ... The time between getting marketing authorisation and companies filing
price detailed in Pfizer’s tiered pricing guidelines.
In Germany, the only country where the pricing details are known, the authorities offered to pay $790, 000 per patient, rising to $950, 000 after five years if the therapy is
Pfizer has also entered into advance purchase agreements with several other countries, as well as committing to “equitable access” at an affordable price for poorer countries through a tiered pricing approach
More from news
Approximately 109 fully matching, plus 912 partially matching documents found.
Accordingly, companies are broadening their early health economics and outcomes research (HEOR), pricing and market access research initiatives and investment on a global scale. ... This list of country-level nuances only scratches the surface. Still, it
to support initial pricing and market access considerations for forecasting, product value, positioning options and patient segmentation?
efficacy, safety, pricing, medicine administration). Test messaging and language. o Engage and learn from the online community (without mentioning your product).
The increased competition also forces originator/biologic manufacturers and sellers to reduce the pricing of their innovative products, further adding to the affordability of important treatments. ... and. lead to supply shortages), to fixed
So why does it go wrong so often? There are many potential reasons, including a lack of engagement with key medical and payer stakeholders, an inadequate pricing and market access strategy
More from intelligence
Approximately 16 fully matching, plus 197 partially matching documents found.
Most recently, she worked in the consultancy’s rare diseases division, where is provided crisis management support in pricing/access barriers for an orphan drug.
Both O’Leary and Massey have experience of delivering evidence-based pricing and market access communications to help build global brands.
Meanwhile Emma Warburton joins the agency as business development executive after previously working as a pricing and market research analyst.
She will also oversee marketing, pricing, forecasting and analytics. Brian Hoffmann, president of Hikma’s generics division, said: “I am looking forward to working closely with Kristy and her team to
Pyati’s new domain will see him grow and expand the group’s scientific and medical communications practice and integrating it with the firm’s analytics, digital and value, pricing and
More from appointments
Approximately 2 fully matching, plus 31 partially matching documents found.
Pharma and biotech, patients, payers, regulators and HTA agencies gathered at the World Evidence, Pricing and Access Congress in March to discuss challenges and potential solutions. ... Pharma and biotech, patients, payers, regulators and HTA agencies
Challenges associated with a rare disease product launch. Launching a product in a rare disease is becoming progressively challenging, with increased competition and pricing pressures, regulators demanding more evidence of therapeutic
Product launches are becoming progressively more challenging, with increased competition and pricing pressures, regulators demanding more evidence of therapeutic value, and patients driving treatment decisions and impacting on success through
Develop innovative pricing and contracting models that resonate with local stakeholder needs. Manage limited time and resources.
See how our client utilized Rapid Payer Response (RPR) to gain invaluable Payer insight into the Pricing and Market Access acceptability of their novel product within 3 Weeks. ... Robust Review: Pricing &Market Access.
More from PMHub
Approximately 6 fully matching, plus 73 partially matching documents found.
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....